🔍

Walchandnagar Industries Limited (WALCHANNAG)

₹213.45 +3.53% last close, 16 Oct

📊 NSE: WALCHANNAG 🏢 Engineering 📢 Latest filing: 13 Oct 2026 📝 Analysis written: 14 Dec 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Walchandnagar Industries' revenue was ₹90.8 Cr (+83.8% year on year, -2.4% on the previous quarter), and net profit ₹1.2 Cr (against a loss a year earlier); the operating margin was 8.1%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹90.8	+83.8%	-2.4%
Operating profit	₹7.3	from loss	+76.9%
Net profit	₹1.2	from loss	-59.9%
EPS (₹)	0.17	from loss	-60.5%
Operating margin	8.1%	—	—

Full quarterly financials → Results calendar →

WALCHANNAG delivery percentage and bulk deals

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 30.55% of the WALCHANNAG shares traded on NSE were taken to delivery, against the stock's own 20-session average of 43.08%. The price rose 3.53% on unusually low delivery, so more of the move than usual was intraday trading. 2 bulk or block deals were reported in WALCHANNAG in the last 60 days: ₹8 Cr bought and ₹9 Cr sold.

30.55%Delivery, 16 Oct

43.08%Own 20-session average

1.1×Volume vs its average

₹213.45NSE close · +3.53%

Delivery in the last 5 sessions: 40.8% · 36.7% · 40.9% · 47.4% · 30.6%

Date	Side	Counterparty	Value	Price	Quantity	Type
7 Oct	Sell	Qe Securities Llp	₹8.79 Cr	₹223.45	393,388	Bulk
7 Oct	Buy	Qe Securities Llp	₹8.45 Cr	₹223.90	377,620	Bulk

Delivery across the market →All bulk and block deals →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Walchandnagar Industries Submits Regulation 74(5) Dematerialisation Certificate for Q2 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 13 Oct 2026, 10:21 AM

Walchandnagar Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The confirmation was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. The document confirms that share certificates received for dematerialisation were verified, cancelled, and substituted in the register of members within prescribed timelines. This is a regular quarterly administrative compliance filing with no impact on business operations or financials.

Compliance certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Pertains to the quarter ended September 30, 2026
Issued by RTA MUFG Intime India Private Limited on October 12, 2026

💡 No action is required as this is a standard regulatory submission; investors should track upcoming Q2 FY27 financial results for operational performance.

Walchandnagar Wins Rs 30.53 Cr Gaganyaan Order from VSSC

🟢 POSITIVE ⭐ 6/10

OTHER 📅 20 Aug 2026, 07:06 PM

Walchandnagar Industries Limited has secured an order worth Rs 3,053 lakhs (Rs 30.53 Cr) plus GST from Vikram Sarabhai Space Centre (VSSC). The contract entails the fabrication, proof pressure testing, and supply of all three segments of HS200 motorcases for the Gaganyaan mission. The order has an execution timeline of 4 years. Raw materials will be supplied by VSSC as Free Issue Materials (FIMs), with no additional tooling reimbursement.

Received a domestic contract valued at Rs 3,053 lakhs (Rs 30.53 Cr) plus GST from VSSC
Scope covers fabrication, proof pressure testing, and supply of 3 segments of HS200 Motorcases for Gaganyaan
Execution timeline is set at 4 years from the date of the contract
Customer to provide raw materials as Free Issue Materials (FIMs); no extra tooling cost compensated

💡 Track milestone-based revenue recognition from aerospace contracts in upcoming quarterly results and monitor overall execution turnaround across the DNAM portfolio.

117th AGM: Shareholders Approve Consultancy Contract Renewal for Chakor L. Doshi

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 12 Aug 2026, 06:24 PM

Walchandnagar Industries Limited (WIL) successfully passed all five resolutions at its 117th Annual General Meeting held on August 11, 2026. A key special resolution to renew the consultancy contract with Mr. Chakor L. Doshi was approved with an 87.43% majority, despite 100% of participating institutional votes (73,581 shares) being cast against it. Other standard resolutions, including the adoption of FY26 audited financial statements and the re-appointment of Mr. Doshi as a director, received overwhelming support exceeding 99.9%. The company also received approval to alter its Registered Office clause in the Memorandum of Association.

Total of 5 resolutions passed at the 117th AGM held on August 11, 2026
Consultancy contract renewal for Mr. Chakor L. Doshi approved with 87.43% of total votes in favor
100% of participating Public Institutional votes (73,581 shares) were cast against the consultancy contract renewal
Adoption of FY26 Audited Financial Statements passed with 99.99% majority (22,088,583 votes)
A total of 103,020 shareholders were eligible to vote as of the August 4, 2026 cut-off date

💡 Monitor the company's execution of its 'DNA' (Defence, Nuclear, Aerospace) sector strategy and its ability to manage its Rs 219 Cr debt while transitioning away from legacy EPC projects.

117th AGM: Shareholders Approve All Resolutions Including Consultancy Contract Renewal

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 12 Aug 2026, 06:13 PM

Walchandnagar Industries Limited (WIL) concluded its 117th Annual General Meeting on August 11, 2026, with shareholders approving all five proposed resolutions. Key approvals included the adoption of FY26 audited financial statements and the re-appointment of Mr. Chakor L. Doshi as Director. A special resolution for the renewal of Mr. Doshi's consultancy contract passed with 87.43% support, despite facing 12.57% opposition from voting members. The company also received approval to amend the Registered Office clause in its Memorandum of Association.

Total of 103,020 shareholders were eligible to vote as of the August 04, 2026 cut-off date
Resolution 1 (FY26 Financials) passed with 99.9936% of total votes in favor
Resolution 3 (Consultancy Renewal) received 87.43% approval, with 80,114 votes cast against it
Resolution 2 (Director Re-appointment) passed with 99.9707% approval across remote and AGM e-voting

💡 Monitor the company's execution in the high-margin 'DNA' (Defence, Nuclear, Aerospace) segments as it pivots away from legacy EPC projects to improve its 4.0% ROCE.

Walchandnagar Industries Amends MOA to Reflect Registered Office Shift to Pune

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 12 Aug 2026, 03:56 PM

Walchandnagar Industries Limited has received shareholder approval at its 117th Annual General Meeting (AGM) held on August 11, 2026, to amend its Memorandum of Association (MOA). The amendment updates Clause II to state that the Registered Office is situated in the 'State of Maharashtra,' replacing the archaic 'Province of Bombay' terminology. This follows a prior special resolution passed on March 08, 2026, which shifted the office from Mumbai to Pune to align with current operations.

Shareholders approved the MOA amendment at the 117th AGM held on August 11, 2026
The Registered Office was officially shifted from Mumbai to Pune via a resolution on March 08, 2026
Clause II of the MOA was updated to replace 'Province of Bombay' with 'State of Maharashtra'
The company maintains a net worth of Rs 359 Cr and debt of Rs 219 Cr as per latest financial context

💡 This is a procedural administrative update. Investors should continue to monitor the company's progress in the high-margin Defence, Nuclear, and Aerospace (DNA) sectors and its ability to resolve legacy debt and labor issues.

₹247.59 Cr Preferential Issue: Walchandnagar Industries Reports Zero Deviation in Fund Usage

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Aug 2026, 08:24 PM

Walchandnagar Industries Limited has submitted its quarterly statement of deviation for the period ended June 30, 2026, regarding funds raised through a preferential issue of convertible warrants. The company confirmed that the total planned raise of ₹247.59 crores is being utilized as per the objects stated in the offer document. Of this, ₹216.00 crores has been received in cash, and ₹31.59 crores was adjusted against outstanding loans. The monitoring agency, ICRA Limited, has reviewed the utilization, ensuring transparency in capital deployment.

Total amount raised or to be raised through preferential warrants stands at ₹247.59 crores.
₹216.00 crores has been received in cash from investors as of the reporting date.
₹31.59 crores was adjusted via conversion or appropriation of outstanding loans.
Monitoring agency ICRA Limited confirmed zero deviation or variation in fund usage for the quarter ended June 30, 2026.
The Audit Committee reviewed and approved the statement on August 11, 2026.

💡 Investors should note this as a routine compliance filing that confirms the company is following its stated financial plan for the 2023 fundraise. No further action is required unless future filings show a deviation in fund usage.

81% Revenue Growth and 6.6x EBITDA Surge in Q1 FY27 for Walchandnagar Industries

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 11 Aug 2026, 08:13 PM

Walchandnagar Industries (WIL) reported a strong Q1 FY27 with total revenue surging 81% YoY to ₹97.80 Cr. Operating profit (EBITDA) expanded 6.6x to ₹14.32 Cr, reflecting improved execution and cost structures. This marks the third consecutive quarter of positive profitability, signaling a structural turnaround from previous losses. The company is successfully pivoting toward high-margin Defence, Nuclear, and Aerospace (DNA) segments, moving away from legacy EPC projects.

Total Revenue increased 81% YoY to ₹97.80 Cr from ₹53.96 Cr in Q1 FY26.
EBITDA surged 6.6x to ₹14.32 Cr compared to ₹2.17 Cr in the previous year's quarter.
Reported a positive PBT of ₹1.18 Cr, a significant recovery from a loss of ₹10.39 Cr in Q1 FY26.
Achieved the third consecutive quarter of positive PAT (Q3 FY26, Q4 FY26, and Q1 FY27).
Revenue from operations alone grew 83.7% YoY to ₹90.83 Cr.

💡 Monitor the sustainability of the 14.6% EBITDA margin and the conversion of the DNA segment order book into revenue. Watch for updates regarding the reduction of the ₹219 Cr debt and the recovery of sticky receivables from TNEB.

117th AGM: Walchandnagar Industries Approves FY26 Financials and Director Re-appointment

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Aug 2026, 07:28 PM

Walchandnagar Industries concluded its 117th Annual General Meeting on August 11, 2026, where shareholders approved the audited financial statements for the year ended March 31, 2026. Key resolutions passed include the re-appointment of Mr. Chakor L. Doshi as Director and the renewal of his consultancy contract. The meeting also approved an alteration to the Registered Office clause in the Memorandum of Association. Representations were received for 2,09,47,015 equity shares, accounting for 30.88% of the company's paid-up capital.

117th Annual General Meeting held on August 11, 2026, via Video Conferencing
Representations received for 2,09,47,015 equity shares, representing 30.88% of paid-up capital
Shareholders approved the renewal of the consultancy contract with Mr. Chakor L. Doshi
Ratification of remuneration for Cost Auditors for the year ending March 31, 2027
All 5 resolutions set out in the notice were passed with the requisite majority

💡 Investors should monitor the company's execution in the specialized DNA (Defence, Nuclear, Aerospace) sectors, which is the primary driver for its targeted 15-20% growth rate.

Walchandnagar Q1 Results: Turnaround to ₹1.18 Cr Profit; Revenue Surges 84% YoY

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 11 Aug 2026, 06:17 PM

Walchandnagar Industries reported a significant turnaround in Q1 FY27, posting a net profit of ₹1.18 Cr compared to a net loss of ₹10.39 Cr in the same quarter last year. Revenue from operations grew by 83.8% YoY to ₹90.83 Cr, primarily driven by the Heavy Engineering segment which contributed ₹70.11 Cr. While the company has returned to profitability, finance costs remain high at ₹10.01 Cr, accounting for approximately 11% of total revenue. The Foundry and Machine Shop segment also showed a sharp recovery, with revenue increasing to ₹15.34 Cr from ₹2.02 Cr YoY.

Revenue from operations increased 83.8% YoY to ₹90.83 Cr from ₹49.43 Cr.
Net Profit turned positive at ₹1.18 Cr vs a loss of ₹10.39 Cr in Q1 FY26.
Heavy Engineering segment revenue grew 66.6% YoY to ₹70.11 Cr.
Foundry and Machine Shop revenue surged to ₹15.34 Cr from ₹2.02 Cr in the previous year's quarter.
Finance costs remained high at ₹10.01 Cr, nearly equal to the total operating expenditure excluding materials and labor.

💡 Investors should monitor the sustainability of this turnaround in subsequent quarters and watch for any reduction in the ₹219 Cr debt pile, as interest costs currently consume a large portion of operating margins.

Walchandnagar Industries Q1 Turnaround: ₹1.18 Cr Profit on 84% Revenue Growth

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 11 Aug 2026, 06:14 PM

Walchandnagar Industries (WIL) reported a significant turnaround in Q1 FY27, posting a net profit of ₹1.18 Cr compared to a net loss of ₹10.39 Cr in the same period last year. Revenue from operations surged 83.7% YoY to ₹90.83 Cr, driven by strong performance in Heavy Engineering and a massive recovery in the Foundry segment. However, finance costs remain a major headwind at ₹10.01 Cr, nearly equal to the operating profit before interest. The company's shift toward specialized 'DNA' (Defence, Nuclear, Aerospace) sectors appears to be gaining traction in the top line.

Revenue from operations grew 83.7% YoY to ₹90.83 Cr from ₹49.43 Cr.
Turned profitable with a PAT of ₹1.18 Cr vs a loss of ₹10.39 Cr in Q1 FY26.
Foundry and Machine Shop segment revenue jumped 659% YoY to ₹15.34 Cr.
Heavy Engineering segment revenue increased 66.5% YoY to ₹70.11 Cr.
Finance costs remained elevated at ₹10.01 Cr, consuming a significant portion of operating margins.

💡 Investors should monitor the company's ability to sustain this profitability and manage its high debt levels (₹219 Cr), as finance costs continue to be a major drag on the bottom line.

Walchandnagar Industries Outlook Revised to 'Stable' from 'Negative'; Ratings Reaffirmed at 'BB'

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 07 Aug 2026, 08:46 PM

ACUITE Ratings has reaffirmed Walchandnagar Industries' long-term rating at 'BB' and short-term rating at 'A4+', while upgrading the outlook to 'Stable' from 'Negative'. This revision follows an operational turnaround in FY26, where revenue grew 6% to Rs 278.11 Cr and EBITDA margins turned positive at 7.84% compared to -25.62% in FY25. However, liquidity remains a concern with negative cash accruals and an intensive working capital cycle of 640 days. The company is targeting a preferential allotment by FY2027 to reduce debt and fund capital expenditure.

Credit outlook upgraded to 'Stable' from 'Negative' on bank facilities totaling Rs 514.51 Cr
FY26 EBITDA margin improved significantly to 7.84% from -25.62% in the previous year
Unexecuted order book stands at Rs 374.56 Cr as of June 30, 2026, providing 1.35x revenue visibility
Working capital cycle remains highly intensive with Gross Current Asset (GCA) days at 640
Recovered Rs 23.74 Cr in partial retention money and Rs 8.28 Cr in bank guarantees from TNEB in FY26

💡 Investors should monitor the company's ability to convert its Rs 374.56 Cr order book into cash flow and the successful execution of the planned preferential allotment by FY2027 to alleviate liquidity pressure.

62,472 Shares Allotted under ESOP 2020 by Walchandnagar Industries

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 03 Aug 2026, 03:14 PM

Walchandnagar Industries Limited has allotted 62,472 equity shares to eligible employees under its Employee Stock Options Plan 2020. The allotment was approved by the Nomination and Remuneration Committee on August 03, 2026. This issuance increases the total paid-up equity capital to Rs. 13.58 crore. The dilution resulting from this specific allotment is minimal, representing approximately 0.09% of the post-allotment share capital.

62,472 equity shares of face value Rs. 2 each allotted to employees
Total paid-up equity share capital increased to Rs. 13,58,09,064
Total number of equity shares post-allotment stands at 6,79,04,532
Allotment made pursuant to the WIL Employee Stock Options Plan 2020

💡 No immediate action required as this is a routine administrative allotment. Investors should monitor the cumulative dilution from the ESOP 2020 plan in annual reports.

CFO Nishant Saigal Resigns, Effective October 19, 2026

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 30 Jul 2026, 05:50 PM

Walchandnagar Industries Limited (WIL) has announced the resignation of Mr. Nishant Saigal from the position of Chief Financial Officer (CFO) and Key Managerial Personnel. The resignation was submitted on July 30, 2026, and will be effective from the close of business hours on October 19, 2026. This leadership change occurs as the company manages a debt of ₹219 Cr and attempts to pivot from legacy EPC projects to high-margin Defence, Nuclear, and Aerospace (DNA) sectors.

Resignation tendered on July 30, 2026, citing better future prospects.
Effective date of cessation is October 19, 2026, providing a nearly three-month transition period.
Company is managing a debt of ₹219 Cr against a net worth of ₹359 Cr (D/E of 0.61).
Recent Sep 2025 quarterly performance showed a net loss of ₹11.9 Cr on revenue of ₹51.78 Cr.

💡 Investors should monitor the company's announcement regarding a successor and ensure the transition does not disrupt the ongoing strategic shift toward specialized OEM manufacturing.

Walchandnagar Industries reports 100% SDD compliance for Q1 FY27

🟡 NEUTRAL ⭐ 2/10

REGULATORY 📅 17 Jul 2026, 03:09 PM

Walchandnagar Industries Limited has submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended June 30, 2026. The company confirmed that 02 events involving Unpublished Price Sensitive Information (UPSI) were required to be captured, and both 02 events were successfully recorded. This filing is a mandatory procedural requirement under SEBI (Prohibition of Insider Trading) Regulations to ensure transparency and prevent information leaks. The database is maintained internally and is designed to be non-tamperable with an 8-year audit trail.

Captured 02 out of 02 required UPSI events during the quarter ended June 30, 2026
Maintains an internal, non-tamperable database with an audit trail capability of 8 years
Certified compliance under Regulation 3(5) and 3(6) of SEBI (PIT) Regulations, 2015
The certificate was signed by the Compliance Officer on July 17, 2026

💡 No action required as this is a routine regulatory filing. Investors should focus on the upcoming Q1 FY27 financial results to assess the company's progress in the Defence and Nuclear sectors.

Walchandnagar Industries to Hold 117th AGM on Aug 11; Reports Q3-Q4 FY26 Operating Profitability

🟢 POSITIVE ⭐ 6/10

BOARD_MEETING 📅 15 Jul 2026, 08:55 PM

Walchandnagar Industries (WIL) has scheduled its 117th AGM for August 11, 2026, following a fiscal year marked by a strategic shift toward Defence, Nuclear, and Aerospace (DNA) sectors. The Chairman reported a structural turnaround, with the company achieving operating profitability in Q3 and Q4 of FY26. Operations at the Foundry division resumed on November 17, 2025, after a seven-month lockout that had previously impacted revenues. Additionally, the company reached a ₹100 Lakh settlement with AICITTA and is seeking shareholder approval for the Chairman's consultancy renewal at ₹80,000 per day.

Achieved consecutive operating profitability in Q3 and Q4 of FY26 before exceptional items
Foundry division resumed normal operations on Nov 17, 2025, following a lockout since April 12, 2025
Settlement reached with AICITTA for ₹100 Lakhs, payable in five installments of ₹20 Lakhs through August 2026
Proposed renewal of Chairman's consultancy contract at ₹80,000 per day for two years (May 2026 - April 2028)
Targeting a DNA sector order book of ₹150-200 Cr for H2 FY26 to drive margin expansion

💡 Investors should monitor if the operating profitability achieved in late FY26 is sustained in the upcoming Q1 FY27 results. Key focus remains on the reduction of the ₹219 Cr debt and the execution of high-precision orders for ISRO and Defence agencies.

View All WALCHANNAG Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue for H1 FY26 was INR 109.03 Cr, a 38.3% decline from INR 176.88 Cr in H1 FY25. On a sequential basis, Q2 FY26 revenue of INR 55.42 Cr grew 2.7% over Q1 FY26. The Heavy Engineering segment showed a sequential growth of 9.0% in Q2 FY26, while the 'Others' segment grew 8.1%. The Foundry business saw a significant decline due to a lockout, generating minimal revenue.

Geographic Revenue Split

Not specifically disclosed in available documents, though the company maintains a global presence with its registered office in Mumbai, Maharashtra.

Profitability Margins

The company reported a PBT loss of INR 22.29 Cr in H1 FY26 compared to a loss of INR 16.88 Cr in H1 FY25. Net profitability is constrained by high interest costs and cost over-runs on specific orders like TNEB. Operating margins are impacted by the intensive working capital cycle and high fixed costs during periods of labor unrest.

EBITDA Margin

EBITDA margin for Q2 FY26 was 1.1% (INR 0.61 Cr) compared to 4.0% (INR 2.17 Cr) in Q1 FY26. H1 FY26 EBITDA margin stood at 2.5% (INR 2.78 Cr), a sharp decline from 6.2% (INR 10.94 Cr) in H1 FY25 due to reduced scale and loss-making segments.

Capital Expenditure

The company utilized a portion of its INR 216.00 Cr preferential issue proceeds for capex and debt prepayment. Specific planned capex includes enhancing capacity for nuclear orders and DNA business segments.

Credit Rating & Borrowing

The long-term rating is 'ACUITE BB' with the outlook revised from 'Stable' to 'Negative' as of May 2025. Short-term rating is 'ACUITE A4+'. The revision reflects a turnaround delay and weak debt protection metrics, with an Interest Coverage Ratio of -0.72x and DSCR of -0.49x in FY25.

⚙️ Operational Drivers

Raw Materials

Specialized steel, alloys, and components for nuclear and aerospace projects represent the primary material costs. Raw material delays from suppliers specifically impacted nuclear project execution in FY25.

Import Sources

Not specifically disclosed, though the company operates in high-tech manufacturing requiring specialized global and domestic sourcing.

Key Suppliers

Not disclosed by name; however, the company noted delays in raw material supply for nuclear projects from specific third-party vendors.

Capacity Expansion

Current focus is on expanding capacity for the DNA (Defence, Nuclear, Aerospace) business. The company is transitioning away from EPC to specialized OEM manufacturing to improve margins.

Raw Material Costs

Raw material costs are a significant portion of the project-based revenue. Delays in procurement and quality inspections for nuclear projects led to a decline in FY25 operating income to INR 259.18 Cr from INR 311.38 Cr in FY24.

Manufacturing Efficiency

Efficiency was severely hampered by a lockout from April 12, 2025, to November 24, 2025, and a previous 43-day strike in FY24 which cost approximately INR 30 Cr in revenue.

📈 Strategic Growth

Expected Growth Rate

15-20%

Growth Strategy

The company aims to achieve growth by focusing on the 'DNA' (Defence, Nuclear, Aerospace) sectors, targeting a healthy order book of INR 150-200 Cr in H2 FY26. Strategy includes leveraging its 116-year legacy to secure high-precision manufacturing orders for government missions and utilizing INR 216 Cr from preferential issues to deleverage and fund execution.

Products & Services

Critical equipment for Nuclear Power Plants, Aerospace components (Chandrayaan I & II), Akash Missiles, Industrial Gears, Centrifugals, Castings, and Gauges.

Brand Portfolio

Walchandnagar Industries Limited (WIL).

New Products/Services

Increased focus on specialized OEM business for Nuclear and Defence sectors, expected to be the primary driver of the positive EBITDA trajectory.

Market Expansion

Expanding presence in the strategic DNAM (Defence, Nuclear, Aerospace, Missiles) sectors to align with India's self-reliance goals.

Market Share & Ranking

Not disclosed as a specific percentage, but recognized as a key player in India's strategic heavy engineering and aerospace sectors.

🌍 External Factors

Industry Trends

The heavy engineering industry is shifting toward high-tech strategic manufacturing. WIL is positioning itself by exiting low-margin EPC and focusing on the growing DNA (Defence, Nuclear, Aerospace) market which offers better long-term visibility.

Competitive Landscape

Competes with other large-scale heavy engineering firms in India, though its niche in nuclear and aerospace precision manufacturing limits the number of direct competitors.

Competitive Moat

The moat is built on a 116-year operational legacy and specialized technical capabilities required for space and nuclear missions (e.g., Chandrayaan). These high entry barriers and long-standing government relationships provide a durable competitive advantage.

Macro Economic Sensitivity

Highly sensitive to government fiscal policy and defense spending. Inflationary pressures on raw materials and labor costs impact project profitability.

Geopolitical Risks

Beneficiary of 'Atmanirbhar Bharat' (self-reliance) initiatives in defense and nuclear sectors, which mitigates risks from global trade barriers.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to stringent quality inspections and standards for nuclear and defense manufacturing. Compliance with SEBI (LODR) and (ICDR) regulations is monitored by ICRA.

Environmental Compliance

The company is ISO 9001:2015 certified and implements energy conservation measures like air compressor element replacement.

Legal Contingencies

A penalty of INR 21.25 Lakhs imposed by SEBI in 2015 regarding promoter entity share purchases is currently pending in the Supreme Court. A provision of INR 4.00 Cr was created for the settlement of Walchandnagar Union Agreements.

⚠️ Risk Analysis

Key Uncertainties

Labor relations remain a key risk, with past strikes and lockouts causing multi-crore revenue losses. Execution delays in long-lead nuclear projects due to supplier issues also pose a risk to the turnaround strategy.